Calle-Guisado Violeta, de Llera Ana Hurtado, Martin-Hidalgo David, Mijares Jose, Gil Maria C, Alvarez Ignacio S, Bragado Maria J, Garcia-Marin Luis J
Research Group of Intracellular Signalling and Technology of Reproduction (SINTREP), School of Veterinary Medicine, University of Extremadura, Caceres, Spain.
Assisted Reproduction Unit at the Minimally Invasive Surgery Center Jesús Usón (CCMIJU) Caceres, Spain.
Asian J Androl. 2017 Nov-Dec;19(6):707-714. doi: 10.4103/1008-682X.185848.
AMP-activated kinase (AMPK), a protein that regulates energy balance and metabolism, has recently been identified in boar spermatozoa where regulates key functional sperm processes essential for fertilization. This work's aims are AMPK identification, intracellular localization, and their role in human spermatozoa function. Semen was obtained from healthy human donors. Sperm AMPK and phospho-Thr172-AMPK were analyzed by Western blotting and indirect immunofluorescence. High- and low-quality sperm populations were separated by a 40%-80% density gradient. Human spermatozoa motility was evaluated by an Integrated Semen Analysis System (ISAS) in the presence or absence of the AMPK inhibitor compound C (CC). AMPK is localized along the human spermatozoa, at the entire acrosome, midpiece and tail with variable intensity, whereas its active form, phospho-Thr172-AMPK, shows a prominent staining at the acrosome and sperm tail with a weaker staining in the midpiece and the postacrosomal region. Interestingly, spermatozoa bearing an excess residual cytoplasm show strong AMPK staining in this subcellular compartment. Both AMPK and phospho-Thr172-AMPK human spermatozoa contents exhibit important individual variations. Moreover, active AMPK is predominant in the high motility sperm population, where shows a stronger intensity compared with the low motility sperm population. Inhibition of AMPK activity in human spermatozoa by CC treatment leads to a significant reduction in any sperm motility parameter analyzed: percent of motile sperm, sperm velocities, progressivity, and other motility coefficients. This work identifies and points out AMPK as a new molecular mechanism involved in human spermatozoa motility. Further AMPK implications in the clinical efficiency of assisted reproduction and in other reproductive areas need to be studied.
AMP 激活的蛋白激酶(AMPK)是一种调节能量平衡和新陈代谢的蛋白质,最近在公猪精子中被发现,它在精子中调节受精所必需的关键功能过程。这项研究的目的是鉴定人精子中的 AMPK、确定其细胞内定位及其在人精子功能中的作用。精液取自健康的人类捐赠者。通过蛋白质免疫印迹法和间接免疫荧光法分析精子中的 AMPK 和磷酸化苏氨酸 172-AMPK(phospho-Thr172-AMPK)。通过 40%-80%的密度梯度分离高质量和低质量的精子群体。在存在或不存在 AMPK 抑制剂化合物 C(CC)的情况下,使用综合精液分析系统(ISAS)评估人类精子活力。AMPK 定位于人精子的整个头部、中段和尾部,强度各不相同,而其活性形式磷酸化苏氨酸 172-AMPK 在顶体和精子尾部染色明显,在中段和顶体后区域染色较弱。有趣的是,带有过量残留细胞质的精子在这个亚细胞区室中显示出强烈的 AMPK 染色。人精子中 AMPK 和磷酸化苏氨酸 172-AMPK 的含量均表现出重要的个体差异。此外,活性 AMPK 在高活力精子群体中占主导地位,与低活力精子群体相比,其强度更强。用 CC 处理抑制人精子中的 AMPK 活性会导致所分析的任何精子活力参数显著降低:活动精子百分比、精子速度、前进性和其他活力系数。这项研究鉴定并指出 AMPK 是一种参与人精子活力的新分子机制。AMPK 在辅助生殖的临床效率和其他生殖领域的进一步影响有待研究。